The Minister for Health, Wicklow TD, Simon Harris says he has been assured that there will be no delay in accessing the drug Spinraza, following a lengthy campaign by parents of those affected.
The HSE’s leadership team has approved access to the drug for children with type 1, 2 and 3 Spinal Muscular Atrophy on an exceptional and individualised basis.
Earlier this year, the HSE said the drug would cost about €600,000 in the first year to treat each of the 25 Irish children with the disease and €380,000 a year thereafter,.
Spinraza is now approved in 26 countries around Europe with just Estonia rejecting it.
Woman Dies In Waters At Wicklow Beach
Wicklow Housing Remains Ireland's Most Expensive Outside Dublin
Wicklow Mountains National Park Issues Wildfire Warning After Days of Blazes at Glencree
39 Jobs To Go In Carnew As ProAmpac Plan To Move Production To Donegal
12 New Charities Registered In Wicklow Last Year As National Concerns Rise By 38%
